Amerisourcebergen

Amerisourcebergen EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amerisourcebergen (ABC) as of Nov 9, 2026 is 3.93 B USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 3.65 B USD — a change of 7.74% (higher).

EBITDA

3.93 BUSD

YoY

7.74%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amerisourcebergen is 2026 3.93 B USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amerisourcebergen was 2025 3.65 B USD. It decreases by 7.74% higher compared to the previous year.

The Amerisourcebergen EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
2.33 B USD
Jan 1, 2020
2.42 B USD
Jan 1, 2021
3.18 B USD
Jan 1, 2022
3.45 B USD
Jan 1, 2023
2.45 B USD
Jan 1, 2024
3.04 B USD
Jan 1, 2025
3.65 B USD
Jan 1, 2026
3.93 B USD
The Amerisourcebergen EBITDA history
YEAREBITDAYoY
3.93 BUSD+7.74%
3.65 BUSD+19.98%
3.04 BUSD+24.26%
2.45 BUSD-29.00%
3.45 BUSD+8.35%
3.18 BUSD+31.65%
2.42 BUSD+3.74%
2.33 BUSD+10.05%
2.12 BUSD-12.43%
2.42 BUSD+17.99%
2.05 BUSD+31.58%
1.56 BUSD+13.24%
1.37 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amerisourcebergen Stock analysis

What does Amerisourcebergen do? AmerisourceBergen Corp is a global healthcare company that offers a variety of products and services to its customers. It was founded in 2001 through the merger of AmeriSource Health Corp and Bergen Brunswig Corp. The company's business model is based on providing products, services, and technologies for various areas of the healthcare industry, including pharmacy, biotechnology, healthcare services, and retail. AmerisourceBergen Corp has three main business segments: Pharmaceutical Distribution Services, Provider Services, and Pharmaceutical Manufacturer Services. The pharmaceutical distribution service provides fast and reliable delivery of drugs and medical devices to pharmacies, wholesalers, and healthcare facilities. The provider service helps patients get the right medications and offers clinical services to medical facilities. The pharmaceutical manufacturer distribution provides support to its customers in the manufacturing, quality control, and marketing of drugs. The company also offers technology solutions that enable more patient-centered care and improve communication between doctors and patients. AmerisourceBergen Corp has extensive experience and expertise in the industry. It operates a wide network of branches and logistics centers worldwide to ensure its customers always receive the products and services they need. The company offers a wide range of pharmaceutical products, specialized disease drugs, biosimilars, vaccines, and medical devices. It also provides services such as consulting on drug manufacturing and approval, as well as logistics, financial, marketing, and information technology services for its customers. Over the years, AmerisourceBergen Corp has received numerous awards for its outstanding performance in the healthcare industry. The company is known for its commitment to patient-centered care and its innovative solutions to healthcare supply chain issues. With a strong reputation for quality and customer satisfaction, AmerisourceBergen Corp remains one of the leading companies in the healthcare industry. Amerisourcebergen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amerisourcebergen stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amerisourcebergen is 3.93 B USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Amerisourcebergen changed from 3.65 B USD to 3.93 B USD, representing a 7.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Amerisourcebergen since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Amerisourcebergen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Amerisourcebergen

All Key Metrics — Amerisourcebergen